The implementation of risk-based monitoring strategies is a critical component to ensure high quality and integrity of the data, reduce costs and eliminate inefficiencies in clinical trials processes. Therefore it is important to design appropriate monitoring plans with the right risk assessment and utilize technology for optimum reporting and analysis.

The session will cover:

• How to achieve TransCelerate's quality of design methodology using PAREXEL's DataLabs^® EDC (Electronic Data Capture)
• Understand technology requirements to seamlessly enable key RBM processes such as SDV, SDR and Targeted Monitoring
• A best practice approach to identifying operational risks through data driven monitoring
• System demonstration

Who Should Attend:
Pharmaceutical and biotechnology professionals involved with managing clinical trials specifically Clinical Operations Leaders, Data Management Teams, and Study Project Managers.

Registration

Registration is complimentary.
A valid business Email address is required to attend.

©2016 PAREXEL International Corp.
195 West Street Waltham, MA, 02451, USA • Tel: +1 781-487-9900

Privacy Policy | Contact Us
If you would like to change or modify your subscription preferences, click here. If you would like to unsubscribe from all PAREXEL marketing communications, click here.
©2016 PAREXEL International Corp.
This communication, including any attachments, is intended only for the person or entity to which it is addressed and may contain confidential material. Any review, retransmission, distribution or other use of this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please destroy any copies, contact the sender and delete the material from any computer. PAREXEL and Your Journey. Our Mission. are registered trademarks of PAREXEL International Corporation or its affiliates in the United States and other jurisdictions.